1. Home
  2. MWH vs IBRX Comparison

MWH vs IBRX Comparison

Compare MWH & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MWH

SOLV Energy Inc. Class A Common Stock

N/A

Current Price

$30.45

Market Cap

8.2B

Sector

Industrials

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$9.40

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MWH
IBRX
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MWH
IBRX
Price
$30.45
$9.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
7
Target Price
$35.42
$12.57
AVG Volume (30 Days)
1.8M
12.0M
Earning Date
03-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.71
EPS
N/A
N/A
Revenue
N/A
$113,288,000.00
Revenue This Year
$51.86
$88.59
Revenue Next Year
$14.78
$131.15
P/E Ratio
$50.60
N/A
Revenue Growth
N/A
668.31
52 Week Low
$26.60
$1.95
52 Week High
$48.40
$12.43

Technical Indicators

Market Signals
Indicator
MWH
IBRX
Relative Strength Index (RSI) 38.27 73.46
Support Level $27.16 $6.69
Resistance Level $31.38 $9.54
Average True Range (ATR) 2.22 0.56
MACD -0.10 0.25
Stochastic Oscillator 5.48 93.14

Price Performance

Historical Comparison
MWH
IBRX

About MWH SOLV Energy Inc. Class A Common Stock

SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: